• LevelJump Healthcare (JUMP) has reported financial results for the first fiscal quarter ended March 31, 2022
  • First quarter revenue from Canadian Teleradiology Services Inc. (“CTS”) operations hit record level at $1,979,860
  • JUMP recorded an EBITDA of $(197,516) and adjusted EBITDA of $33,484 for Q1
  • LevelJump currently provides radiology solutions for hospitals, emergency rooms and private clinics
  • Leveljump Healthcare Corp. (JUMP) was up 7.14 per cent, trading at C$0.15 per share at 3:00 pm ET

LevelJump Healthcare (JUMP) has reported financial results for the first fiscal quarter ended March 31, 2022. 

Financial and operational highlights:

  • First quarter revenue from Canadian Teleradiology Services Inc. (“CTS”) operations hit record level at $1,979,860
  • Gross profit from CTS operations was $495,176, at 25 per cent margin
  • Q1 revenue increased by $419,139, a 27 per cent increase YoY
  • CTS completed acquisition of 3 diagnostic imaging centers in Belleville and Cobourg, Ontario
  • Credit facility of $3.2 million secured from TD Canada Trust at 4.02 per cent

2021 Q1 financial results for Leveljump:

  • JUMP recorded an EBITDA of $(197,516) and adjusted EBITDA of $33,484 for Q1

Mitch Geisler, CEO of LevelJump commented on the results.

“We had another record quarter of revenue with positive adjusted EBITDA. CTS continues to grow each quarter as the demand for our teleradiology services increases. Additionally, we acquired three clinics providing crucial services to the communities they serve. The Company continues to focus on broadening it’s telehealth solutions, increasing its radiology services for critical care and show growth organically and through strategic acquisitions.”

LevelJump Healthcare is building a national telehealth medical company and brand. LevelJump currently provides radiology solutions for hospitals, emergency rooms and private clinics.

Its telehealth services are designed to provide doctor to doctor collaboration and diagnosis allowing for efficient and effective patient care. Additionally, JUMP owns and operates independent healthcare facilities (IHF’s) focused on diagnostic imaging.

Leveljump Healthcare Corp. (JUMP) was up 7.14 per cent, trading at C$0.15 per share at 3:00 pm ET.

More From The Market Online

Avicanna finishes study of CBD cream’s use for rare skin disorder

Avicanna (TSX:AVCN) completes an observational study of its RHO Phyto-branded Ultra CBD topical cream on patients with epidermolysis bullosa.
labratory work

PharmaTher locks in FDA-assigned goal date of abbreviated NDA

PharmaTher Holdings (CSE:PHRM) locks in its U.S. FDA-assigned goal date of abbreviated new drug application for Oct. 29, 2024.

Optimi Health makes first international MDMA shipment

Optimi Health (CSE:OPTI) makes its first international shipment of MDMA to The Institute for Psychedelic Research at Tel Aviv University.

Oncolytics Biotech approved to expand pancreatic cancer program

Oncolytics Biotech (TSX:ONC), a cancer immunotherapy stock, receives ethics and German regulatory approvals for a new pancreatic cancer study.